Prognostic Factors and Recurrence in Breast Cancer: Experience at the National Cancer Institute of Mexico
Author(s) -
Armen Stankov,
Enrique BargallóRocha,
A. Ñamendys-Silva Silvio,
M. T. T. Ramirez,
K. Stankova-Ninova,
Abelardo MenesesGarcía
Publication year - 2012
Publication title -
isrn oncology
Language(s) - English
Resource type - Journals
eISSN - 2090-567X
pISSN - 2090-5661
DOI - 10.5402/2012/825258
Subject(s) - cancer , breast cancer , medicine , oncology
The purpose of this study was to analyze the prognostic and predictive factors that relate to locoregional or distant recurrences in breast cancer patients who have been treated at the National Cancer Institute of Mexico. Multivariate, time-dependent Cox regression analyses indicate that the pN status (positive versus negative lymph node; P = 0.003; HR (hazard ratio), 3.47; CI (confidence interval), 1.52–7.91) and the pathological complete response of the patient to neoadjuvant chemotherapy (yes versus no; P = 0.061; HR, 0.38; CI, 0.14–1.04) were important prognostic factors for recurrence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom